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doi:10.1016/j.jmii.2009.12.001We describe a previously unreported condition of severe, recurrent lupus enteritis accompa-
nied with severe hypocomplementemia as the initial and only presentation of systemic lupus
erythematosus. Systemic lupus erythematosus should be suspected in any patient with
computed tomography findings of enteral vasculitis or ischemic enteritis, even without
lupus-related symptoms or signs; C3/C4 levels may be helpful in the differential diagnosis. If
the symptoms do not improve after medical treatment, such as using steroid or cyclophospha-
mide pulse therapy, or necrosis and perforation of the intestines are highly suspected, surgical
intervention should be considered.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Gastrointestinal (GI) manifestations in patients with
systemic lupus erythematosus (SLE) are common; and
anorexia, nausea, and vomiting are the most frequentf Rheumatology and Immu-
ine, Jen-Ai General Hospital,
aiwan.
sa.hinet.net (A.-P. Huo).
an Society of Microbiology. Publsymptoms seen in around 50% of these patients.1 These GI
symptoms may be because of the lupus itself as a result of
bowel ischemia secondary to mesenteric vasculitis or
serositis, a side effect of medication used for SLE treat-
ment, or the coincidence of solely GI manifestations, such
as gastritis, cholecystitis, pancreatitis, appendicitis, colitis,
and so on. It is a challenge for clinicians to immediately
determine the cause of GI symptoms in lupus patients, and
early treatment is also important for long-term survival and
prognosis.2 The most serious GI manifestation of SLE is
ischemia secondary to vasculitis. The reported incidence ofished by Elsevier Taiwan LLC. All rights reserved.
Figure 1. Systemic lupus erythematosus with mesenteric
vasculitis in a 49-year-old woman. Oral contrast material axial
computed tomography scan at a lower level shows diffuse
circumferential bowel wall thickening in the small intestine
and rectosigmoid colon and massive ascites.
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53%1,3 and was correlated with a mortality rate as high as
53% if complicated with hemorrhage, ulceration, infarc-
tion, or perforation, or if treatment or diagnosis is
delayed.4 Lupus patients may present with recurrent
mesenteric vasculopathy producing repeated episodes,
with each exacerbation similar in character and quality.2
Some of these episodes were accompanied with signifi-
cant hypocomplementemia.5 Table 1 summarizes the
related literatures, which focus on recurrent lupus enter-
itis. Here, we describe a previously unreported condition of
severe, recurrent lupus enteritis accompanied with severe
hypocomplementemia as the initial and only presentation
of SLE.
Case report
A 49-year-old healthy woman was admitted to our GI ward
because of nausea, vomiting, and mild right upper quad-
rant pain and fullness sensation with poor intake for 1
week. Physical examination only revealed mild tenderness
in the right upper quadrant without muscle guarding or
rebounding pain. Laboratory examination revealed the
following: white blood cell: 7,130/cumm; seg/lym: 76.8%/
16.8%; hemoglobin: 11.4 mg/dL; hematocrit: 34.2%;
platelet count: 257,000/cumm. Erythrocyte sedimentation
rate was 47 mm/hr. Biochemistry results were as follows:
aspartate aminotransferase: 21 U/L; alanine aminotrans-
ferase: 5 U/L; alkaline phosphatase: 123 U/L; C-reactive
protein: 0.2 mg/dL; blood urea nitrogen/creatinine: 20/
0.7 mg/dL; serum sodium level: 134 meq/L; potassium
level; 4.1 meq/L. Upper GI endoscopy examination
revealed hyperemia in the antrum with distended stomach,
but no ulceration or other abnormalities were found.
Colonoscopy revealed colitis throughout the colon, without
ulceration or diverticulum. Urinalysis revealed no abnor-
malities. Abdominal sonography revealed negative findings
except for moderate ascites. Computed tomography (CT)
examination revealed intestinal wall swelling of the small
and large bowel and rectum with massive ascites (Fig. 1).
Ischemic enteritis was suspected initially, and the patient’s
symptoms improved gradually after no oral alimentation
with bowel rest only. She was discharged with no abdom-
inal discomfort after oral intake on hospital day 11 without
any surgical intervention. After excluding other causes of
ischemic enteritis, the patient’s autoimmune profile was
checked 1 day before discharge because of suspicion of
lupus enteritis based on CT image findings. Laboratory dataTable 1 Summary of the related literature regarding recurrent
Author(s) Findings related to researches
Lian et al.2 Patients treated with cyclophosphamide
Kishimoto et al.5 Patients with recurrent lupus enterocolit
by significant hypocomplementemia. The
cessation of the flares in one patient.
Kwok et al.8 SLE patients with preexisting APS had a
Kim et al.9 In patients with nonrecurrent lupus ente
treatment with prednisolone was signific
APSZ antiphospholipid syndrome; GIZ gastrointestinal; SLEZ systemrevealed a low serum complement level (C3/C4: 48.2/
7.9 mg/dL, normal range: 90e180/10e40 mg/dL), positive
antinuclear antibody (homogenous: 1:80, speckle pattern:
1:320), and anti-ds-DNA antibodies: 1:10 (immunofluo-
rescence assay) 1 day after discharge. Lupus enteritis was
diagnosed and prednisolone treatment with an initial
dosage of 30 mg/day was prescribed 2 weeks later at the
outpatient department although no abdominal symptoms
were mentioned. The prednisolone dosage was tapered to
20 mg/day 1 week later and finally to 5 mg/day the next
week (about 2 months after discharge). However, because
of poor drug compliance, the patient was readmitted to our
ward 4 months after discharge with progressive abdominal
pain, nausea, vomiting just after intake, and total intes-
tinal obstruction with no stool passage for 1 week. Physical
examination revealed abdominal fullness with whole
abdominal tenderness, but no obvious rebounding pain or
muscle guarding was noted. Laboratory analyses revealed
white blood cell: 27,170/cumm; seg/lym: 88%/5%; band
forms 3%; hemoglobin: 17.2 g/dL; hematocrit: 49.6%;
platelet count: 426,000/cumm; and C-reactive protein:
0.8 mg/dL. Prothrombin time and activated partial throm-
boplastin time were within normal range. Biochemistry
analyses revealed blood urea nitrogen/creatinine: 29/
2.4 mg/dL; aspartate aminotransferase/alanine amino-
transferase: 110/60 U/L; alkaline phosphate: 388 U/L;lupus enteritis
had less recurrent GI disease.
is manifest as reversible intestinal wall edema accompanied
institution of mycophenlate mofetil was associated with a
tendency to recur more frequently.
ritis, the cumulative dose of prednisolone and duration of
antly higher than in patients with recurrent lupus enteritis.
ic lupus erythematosus.
154 H.-P. Lin et al.total bilirubin: 0.6 mg/dL; sodium/potassium: 135/
4.3 meq/L; amylase/lipase: 57/50 U/L. Venereal Disease
Research Laboratory test was negative. Urinalysis revealed
negative findings. Abdominal sonography revealed a great
deal of ascites, with dilated intestine without peristalsis.
CT scan revealed diffuse intestinal wall swelling of the
small and large bowel and the rectum with fluid accumu-
lation in the distal esophagus, stomach, and small and large
intestinal lumen accompanied with massive ascites (Fig. 2).
A low complement level was noted again, with C3/C4:
37.6/11/7 mg/dL without any other symptoms of lupus
erythematosus. The autoimmune profile was positive for
anti-ds-DNA antibodies and classical antineutrophil cyto-
plasmic antibodies (c-ANCA) but negative for anti-smooth
muscle antibody, anti-cardiolipin antibodies, anti-mito-
chondrial antibodies, anti-smooth muscle antibodies, and
perinuclear ANCA. Severe dehydration complicated with
hypovolemic shock and acute renal failure developed
within 8 hours after admission; intravenous methylpred-
nisolone (MTP) 40 mg Q12H was given initially but with
a poor response. Because of acute renal failure with oli-
gouria, emergent hemodialysis was performed, and MTP
was tapered to 40 mg QD because of an unstable condition
and suspected sepsis. Her general condition improved
a little after intravenous administration of metronidazole
and ceftriaxone, but total intestinal obstruction without
any stool passage persisted and was later complicated with
obstructive jaundice, which was highly suspected because
of obstruction of ampulla of Vater caused by severe
duodenal wall swelling and edema. Because of a poor
response to steroid therapy, high-dose MTP pulse therapy
was begun at 500 mg/day for 3 consecutive days 10 days
after readmission. She died of sepsis 3 days after starting
MTP pulse therapy.
Discussion
Correctly evaluating and treating lupus patients with GI
symptoms is challenging, and it is even more difficult to
promptly diagnose and treat middle-aged womenFigure 2. Axial computed tomography scan obtained after
administration of intravenous and oral contrast material show
the dilated, fluid-filled small bowel loops with ascites.presenting only with GI symptoms and without a history of
SLE or its correlated symptoms. Zizic et al.4 reported that
in patients with SLE, abdominal vascular syndromes are
highly correlated with the presence of peripheral vascu-
litis, central or peripheral nervous system involvement,
thrombocytopenia, and circulating rheumatoid factor. Lian
et al.2 reported that lupus enteritis occurs when patients
have laboratory markers of active disease and a raised SLE
disease activity index (SLEDAI) score. Buck et al.6 reported
that only those patients with a SLEDAI score of more than
eight developed vasculitis and suggested the routine use of
CT to diagnose vasculitis only in patients with a SLEDAI
score more than eight and subacute abdominal pain.
Medina et al.3 reported that a SLEDAI score below 5 was
a strong indicator that the abdominal complication was not
because of SLE. However, Lee et al.7 demonstrated that
the SLEDAI score was similar at the time of acute abdom-
inal pain in both patients with mesenteric vasculitis and
those with other causes of acute abdominal pain. They also
showed that the SLEDAI score calculated at the time of
acute abdominal pain was lower than that at diagnosis of
SLE in patients with mesenteric vasculitis. Because GI
symptoms are not weighted in the SLEDAI score, and
hypocomplementemia was found in most reported cases
1,2,4,5,7e10 and in our patient, the serum C3/C4 level rather
than the SLEDAI score may able to predict whether the GI
symptoms in lupus patients are related to SLE itself or
other nonlupus causes.
Lupus enteritis may be recurrent, and the jejunum and
the ileum are the most common sites of GI involvement.8,11
The recurrence rate of lupus enteritis is correlated with
a lower cumulative dosage of prednisolone and a shorter
duration of treatment.9 Although necrosis and perforation
have been considered possible end results of lupus enter-
itis, suggesting the need for early surgical intervention to
improve outcome,3,4 the finding that early medical
management, such as steroid pulse therapy, had a good
response in severe cases10 and that cyclophosphamide
pulse therapy may be effective if high-dose steroid treat-
ment failures have indicated that early medical therapy
may be effective.12 In steroid-resistant recurrent cases,
oral mycophenolate mofetile may be another choice.5 Our
patient’s death was related to poor drug compliance and
delay in seeking treatment; and in addition to severe
dehydration, her acute renal failure may be related to the
presence of c-ANCA, which correlated to the crescentic
lupus nephritis. Surgery was not considered because of
diffuse alimentary track involvement from esophagus to the
colon and her critical condition. Because sepsis developed
after starting high-MTP pulse therapy, cyclophosphamide
treatment could not be given. Early cyclophosphamide
treatment thus might have prevented the death of this
patient.
Byun et al.11 suggested that ischemic bowel disease
because of vasculitis should be highly suspected if at least
three of the following signs are noted on the abdominal CT
scan of a lupus patient with acute abdominal pain: bowel
wall thickening, target sign, dilatation of intestinal
segments, engorgement of mesenteric vessels, and
increased attenuation of mesenteric fat. Although our
patient’s presentation only fulfilled three items of the
revised diagnostic criteria for the classification of SLE
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and lymphopenia), her CT findings, laboratory data,
including c-ANCA(þ) and low C3/C4, and improved condi-
tion with oral steroid treatment at the outpatient depart-
ment indicate that the differential diagnosis could only be
focused on lupus enteritis (lupus vasculitis or lupus seros-
itis). The pathologic changes of lupus enteritis caused by
vasculitis are seen in small vessels in the bowel wall rather
than in the medium-sized muscular arteries of the mesen-
tery; thus, angiography and CT scan are usually not helpful
in the diagnosis.4 In our patient, although no mesenteric
vessel engorgement was found in the CT scan and no
pathology tissue sample was available, no clinical symp-
toms related to c-ANCA(þ) vasculitis (Churg-Strauss vascu-
litis, Wegener’s granulomatosis, and microscopic
polyangitis) were found, and no other clinical manifesta-
tions of vasculitis that were not related to SLE (polyarteritis
nodosa, giant cell arteritis, Takayasu’s arteritis, Buerger’s
disease, and Henoch-Schonlein purpura) were identified.
Therefore, the diffuse small artery vasculitis in the
alimentary track or the diffuse intestinal serositis related
to SLE may have been the cause of this complication.
In conclusion, recurrent lupus enteritis may be the initial
and only presentation of SLE; early diagnosis and treatment
with high-dose steroid or even pulse cyclophosphamide
infusion may lead to a good response. SLE should be sus-
pected in any patient with CT findings of enteral vasculitis or
ischemic enteritis, even without lupus-related symptoms or
signs, and C3/C4 levels maybe helpful in the differential
diagnosis. If symptoms do not improve after medical treat-
ment, or necrosis and perforation of the intestines are highly
suspected, surgical intervention should be considered.
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